This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Godemann, F. Articles by Linden, M. Search for Related Content PubMed PubMed Citation Articles by Godemann, F. Articles by Linden, M. Related Collections Anxiety Other Cardiovascular Medicine

Classic Conditioning and Dysfunctional Cognitions in Patients With Panic Disorder and Agoraphobia Treated With an Implantable Cardioverter/Defibrillator

From the Departments of Psychiatry (F.G., B.A., R.B., C.G., M.L.) and Cardiology (S.B., F.L.), Free University of Berlin, Berlin, Germany.

Address reprint request to: Dr. Frank Godemann, Hindenburgdamm 30, 12200 Berlin, Germany. Email: godemann{at}zedat fu-berlin.de

	ABSTRACT

TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES

 
OBJECTIVE: A model for the development of anxiety disorders (panic disorder with or without agoraphobia) is needed. Patients with an implantable cardioverter/defibrillator (ICD) are exposed to repeated electric shocks. If the theory of anxiety development by aversive classic conditioning processes is valid, these repeated shocks should lead to an increased risk of anxiety disorders. To study this hypothesis, we retrospectively studied 72 patients after implantation of an automatic ICD.

METHODS: Patients were assessed with the semistructured Diagnostic Interview of Psychiatric Disease 1 to 6 years after implantation of an automatic ICD. Panic disorder and/or agoraphobia was diagnosed in patients who fulfilled all DSM-III-R criteria for those conditions.

RESULTS: Anxiety disorder developed in 15.9% of patients after ICD implantation. This was significantly related to the frequency of repeated defibrillation (shocks) to stop malignant ventricular arrhythmias. Dysfunctional cognitions are an additional vulnerability factor.

CONCLUSIONS: The data support both the conditioning hypothesis and the cognitive model of anxiety development. These findings suggest that ICD patients are an appropriate risk population for a prospective study of the development of anxiety disorders.

Key Words: implantable cardioverter/defibrillator • panic disorder • agoraphobia.

Abbreviations: DIPS = Diagnostic Interview of Psychiatric Disease; DSM-III-R = Diagnostic and Statistical Manual of Mental Disorders, third edition revised; ICD = implantable cardioverter/defibrillator; PTSD = posttraumatic stress disorder; SAD = subthreshold anxiety disorder; SCL-90-R = revised Symptom Checklist 90.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES

 
Panic disorders and/or agoraphobia have a lifetime prevalence of 2.5% to 3% (1, 2) and are thus epidemiologically prominent among psychiatric disorders. Convincing findings and plausible theories on the development and maintenance of anxiety disturbances exist. Apart from biological (3, 4) and genetic findings (5), many results point to classic conditioning processes and dysfunctional cognitions as vulnerability factors for panic disorders and/or agoraphobia (6–9).

A comprehensive uniform theoretical model is not yet available for the development of panic disorders and phobias. Reinicker (10) points out that the conditions under which phobias develop cannot be determined either generally or individually because no observers are present when they develop. Research thus far has led to a theoretical pluralism in which learning theory–based conditioning models and cognitive theories play an important role.

Mowrer (11) explained in the two-factor theory that situations that definitely trigger an anxiety reaction (eg, innate ones) become linked to neutral stimuli within the context of spatial and temporal association and can then evoke an anxiety reaction by themselves. This process is known as classic conditioning. These learned anxiety reactions are subject to habituation unless there is subsequent avoidance behavior. Avoidance would maintain the anxiety reaction by acting as a negative reinforcement under an operant conditioning paradigm.

Retrospective interviews point to conditioning experiences as triggering factors in nearly 90% of agoraphobia cases (12). In addition, there have been positive findings from aversion therapy. Here aversive avoidance reactions to the target stimulus (eg, drugs) result from the respective conditioning processes (13, 14).

During panic attacks, patients interpret their bodily sensations as a catastrophic event (7, 10, 15). Moreover, Lazarus (16) points out that people are always appraising their coping options for overcoming dangers. Ehlers et al. (9) emphasize selective focusing on normal interoceptive stimuli (eg, heart beat). This altered perception does not correspond to any real improvement in the ability to appraise bodily changes (17).

Beck et al. (6) indicate that the physical experience of anxiety becomes a personal threat. In conjunction with readiness reactions, these fears lead to psychophysiological changes (eg, hyperventilation and tachycardia), which in turn confirm the anxieties and reinforce the fears. According to behavioral theories, an attempt is then made to interrupt this vicious circle by avoiding outer and inner stimuli.

These theories are based on individual case observations, observations of subjects with chemically induced panic attacks (9, 17), and control group examinations (patients with panic disorders vs. healthy, depressive, and somatically ill patients) (18–20). However, it has not yet been possible to test or develop these theories in a prospective manner. The estimated incidence of these disorders is too low (approximately 0.1%) (21) for a prospective investigation. Therefore, it would be of great scientific value to identify a high-risk population with an incidence high enough to warrant a prospective study.

Somatic conditions cause sufficient stress to trigger frequent panic attacks, which may lead to the development of an anxiety disorder. Such an increased prevalence of panic attacks and anxiety disorders has been reported in conjunction with various somatic conditions. Particularly high risk seems to be associated with conditions whose clinical symptoms coincide to some extent with those of the panic attack (eg, palpitations, vertigo, and dyspnea). Thus, an increased incidence of anxiety disorders is found in patients with lung diseases (8, 22–25), heart diseases (angina pectoris) (26), and vestibular disorders (27, 28).

Implantation of an ICD for treatment of malignant ventricular arrhythmias is also known to be associated with an increased risk of anxiety (29–31) and anxiety disorders (32). The short-term release of high energy by an ICD is an effective technique for stopping life-threatening arrhythmias (33, 34). Mortality can be markedly reduced by this therapy compared with pharmacological antiarrhythmic treatment (35, 36). On the other hand, this therapy involves the application of a repeated, uncontrolled, irregular, and very aversive stimulus. Theoretically it should, in terms of an unconditioned stimulus, lead to an unconditioned reaction with the development of a conditioned stimulus and conditioned reaction. The development of phobia mediated by anticipatory cognitions would then cause preventive avoidance behavior. Progressive avoidance behavior could then result in agoraphobia.

However, the literature does not provide adequate information on the incidence of anxiety disorders after implantation of an ICD. Chevalier et al. (37) reported a 20% prevalence in 30 patients, but they did not provide data indicating when the anxiety disorders developed. Moreover, generalized anxiety disorder was diagnosed in four of the six patients. Morris et al. (38) found one case of panic disorder among 20 patients with an ICD. About 50% had some type of psychiatric disorder. Bourke et al. (39) reported three cases of agoraphobia and panic disorder among 35 ICD patients. All other authors have reported only individual cases (40, 41) or have assessed anxiety by using self-ratings (29, 42, 43).

We examined the prevalence and particularly the incidence of panic disorders and/or agoraphobia in 72 patients after ICD implantation to determine whether these somatically affected patients represent a high-risk population for the development of anxiety disorders.

	METHODS

TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES

 
ICD implantation has been performed in the Department of Cardiology at the University Hospital Benjamin Franklin since 1989. About 250 patients are currently involved in the outpatient follow-up program to monitor ICD function and to make readjustments. A semistructured interview (DIPS) (44) was used to assess all available patients (local residents) who provided informed consent and who were considered to be intellectually and physically fit for participation. The interview, which focuses on the diagnosis of anxiety disorders, registers both the presence of a mental disorder and the time at which it developed. Three patients whose anxiety disorders had developed before ICD implantation were excluded from the statistical analysis. In addition, avoidance behavior and anxiety level were measured with the SCL-90-R (45).

Sixty-one of the 250 patients were excluded (not assessed) because they lived outside Berlin, as were 11 others who had speech, intellectual, or physical restrictions. Nineteen patients agreed to participate but then could not be reached by phone. Five patients were excluded at the request of the Department of Cardiology. Another 46 patients were excluded because their ICD had been implanted for <1 year.

Of the remaining 108 patients, 36 refused to be interviewed. Two of these patients reported that their great fear of leaving the house since implantation of the ICD would prevent them from appearing for an additional examination. Thus, a total of 72 patients were assessed.

Apart from the psychiatric diagnosis, a 10-item self-assessment scale was used to record the mode of cognitive coping with shocks experienced to identify variables that are more frequent in patients with anxiety disorders after ICD implantation. Patients specified the extent of their agreement with various statements using a five-point Likert scale ("do not agree" to "agree fully"). The items were selected with reference to the most important cognitive theories of panic disorder (including increased self-observation and catastrophic thoughts). Forty-eight patients with at least one ICD discharge filled out this questionnaire. We developed this questionnaire specifically for this study and preferred it to others, such as the Agoraphobic Cognitions Questionnaire (46), which we think lack specificity in relation to experienced shocks. We also recorded the severity of cardiac insufficiency as indicated by the New York Heart Association classification, which ranges from I (no discomfort with normal stress) to IV (dyspnea at rest); left ventricular ejection fraction; and the number of shocks delivered by the ICD.

	RESULTS

TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES

 
The patient sample comprised 62 men and 10 women with a mean age of 69.1 (SD = 10.4) years. Mean ejection fraction was 43% (SD = 16.2%). The severity of cardiac insufficiency (New York Heart Association classification) was as follows: no signs of cardiac insufficiency, 2 patients; class II, 14 patients; class III, 45 patients; and class IV, 11 patients. The 28 patients who declined to participate in the interview did not differ significantly from participants in age, ejection fraction, or number of shocks.

Prevalence and Incidence of Panic Disorders and Agoraphobia
Fourteen patients (19.4%) fulfilled the criteria for agoraphobia and/or panic disorder. In 3 of these 14 patients, the anxiety disorder had developed before ICD implantation. There were clear indications that the anxiety disorder had started to develop during the first year after implantation in the remaining 11 of 69 patients (15.9%). These patients showed a significantly higher phobic avoidance (p < .001) but did not have a significantly higher anxiety level on the SCL-90-R (43). Patients with anxiety disorders were significantly younger (p < .05). In addition, a newly developed subdiagnostic anxiety disorder was observed in 10 patients. This subthreshold group included patients who had dysfunctional avoidance but lacked one of the DSM-III-R criteria for panic disorder or agoraphobia (47). This could mean, for example, that the patients no longer made phone calls because they had experienced a shock during a telephone conversation. Avoidance of flights or sexual intercourse, for example, was not counted because physicians’ recommendations for flights differ and because sexual activity can considerably increase the pulse rate, which can trigger the defibrillator in some patients. Of the 11 patients with anxiety disorder, 1 fulfilled the criteria of a depressive disorder; 2, of a social phobia; and 3, of a specific phobia. Among the 58 patients without anxiety disorder, these criteria were fulfilled by 4, 0, and 3 patients, respectively. All the specific phobias developed before ICD implantation.

Physiological and Psychological Features in Patients With Agoraphobia and Panic Disorder After ICD Implantation
ICD shocks occurred in 48 of 69 patients during follow-up. A comparison of ICD patients with and without panic disorders and/or agoraphobia according to DSM-III-R criteria ( Table 1) showed that patients with anxiety disorder had a significantly higher rate of ICD shocks, defibrillation episodes, and shock clusters. A defibrillation episode was defined as a tachyarrhythmic episode in which one or more ICD shocks were delivered and lasted until the patient was free from additional ICD shocks for at least 1 hour (48). A shock cluster is defined as more than five discharges within 24 hours. On the other hand, there were no significant differences with respect to the severity of cardiac insufficiency. Resuscitated patients had significantly fewer anxiety disorders than patients who received an ICD for other reasons. Resuscitated patients did not regard ICD discharge as a sign of security (resuscitated patients: mean = 3.3, SD = 1.5; patients with syncope or ventricular tachycardia: mean = 3.2, SD = 1.6; t = 1.25, p = .217).

The logistic regression analysis ( Table 3) of variables found to be significant on univariate testing revealed a considerably increased risk for the development of anxiety disorders in patients who have a high concern with their own body (odds ratio = 3.3) and experience a great number of discharge clusters (odds ratio = 3.7). Patients were correctly assigned to the groups with and without anxiety disorders in 89.1% of the cases. Sex, resuscitation experience, and severity of cardiac insufficiency were not significant in this model. The bivariate correlation of subjective concern with the body and the number of clusters was likewise not significant (r = 0.24, Spearman).

	DISCUSSION

TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES

In the 69 ICD patients examined, the significant relation between anxiety and the frequency of shocks and shock clusters supports the role of classic conditioning in the development of panic disorders and agoraphobia. Shocks are a sudden aversive stimulus for ICD patients. A perceived increase of the pulse or irregularities are recognized by patients as premonitory signs. The shock is painful and thus jeopardizes the patients’ feelings of security. Thus, accessory anxiety symptoms frequently develop after the shock. Malignant tachycardias interrupted by the shock are sometimes accompanied by a brief loss of consciousness. This can be experienced by the patient as a loss of control. As in classic conditioning, the psychovegetative anxiety reaction may become connected with formerly neutral stimuli, which can then evoke anxiety symptoms even in the absence of the original stressor. These stimuli are then avoided (operant conditioning), and agoraphobic symptoms can thus develop (eg, a patient refuses to use a telephone after a shock was delivered during a phone call). Also, the ICD discharges can trigger dysfunctional catastrophic cognitions about the meaning of threatening life events and situations or the consequences of experienced symptoms.

Reports in the literature about the effect of discharges on anxiety are contradictory. Schöhl et al. (50) and Herrmann et al. (29) found an association between anxiety after ICD implantation and the experience of shocks. In contrast, Chevalier et al. (37) reported no difference in anxiety levels between shocked and nonshocked ICD patients. Pauli et al. (42) likewise found no relation between the number of shocks per year and the level of anxiety, but they did find a clear relation to the catastrophic fear of dying (p = .001). They concluded that classic conditioning plays a subordinate role in anxiogenesis. Differences between our own findings and those published in the literature can be partially explained by the fact that an average of only 2.5 shocks were recorded in the 61 patients studied by Pauli et al. (42), compared with 8.2 in our 69 patients. The interpretation of these findings is limited because the number of shocks per year is lower in our sample. In contrast, Dunbar et al. (51) reported that anxious patients more often have arrhythmia events. Thus, there seems to be a complex interaction between shocks and anxiety symptoms. It must be stressed, however, that this finding cannot explain the development of complex diseases like anxiety disorders. Being anxious may possibly be a risk factor for both arrhythmic events and anxiety disorders.

Shock clusters put patients under high psychological stress. Thus, shock clusters occurred five times more frequently in patients with anxiety disorders than in those without them. Hamner et al. (52) presented three case reports on ICD patients with PTSD. Because clusters of shocks are an extreme experience for patients, it is remarkable that in our group, only one ICD patient reported marked hypervigilance and nocturnal wakening as occurs with PTSD. It is also interesting that a significantly lower number of resuscitated patients developed anxiety disorders, which may be due to the fact that resuscitation occurs when the patient is unconscious. In summary, the data indicate that the development of anxiety disorders depends on the strength of the stressor as well as on personal vulnerability factors.

The 11 ICD patients with anxiety disorders observed their own body more intensively to check for irregularities. They were convinced that they could reliably detect threatening signs. This finding is in line with those of Hegel et al.(53), who also reported clinically relevant anxiety in one-third of 38 ICD patients and found that the belief of ICD patients in their ability to predict ICD shocks is closely connected with anxiety. Moreover, Pauli et al. (42) demonstrated that the degree of fear of a renewed shock is closely related to the intensity of the avoidance behavior and panic-related cognitions. It is conceivable that some patients may react with anxiety after erroneously interpreting pulse changes as a danger and premonitory sign indicating a renewed shock. The connection between (usually) harmless somatic manifestations and the fearful memory of the shock in terms of a catastrophic association may be a further step in the development of an anxiety disorder in that the misinterpretation evokes anxiety, which in turn leads to a psychovegetative reaction. This can give rise to thoughts of losing control ("I’ll be lying helpless somewhere, and nobody will come to rescue me") or being vitally threatened ("I’m going to die"). This in turn enhances the anxiety and the psychovegetative reaction. Thus, the vicious circle of anxiety is set into motion as is typical for panic disorders and agoraphobia. Reiss (54) concluded that to predict panic, it is more important to know what an individual expects to happen as a result of becoming anxious than to know how frequently they experience anxiety states.

The first occurrence of panic attacks can be explained by a vulnerability-stress model (55). The vulnerability-stress model assumes that any individual can develop panic attacks under sufficient stress and that the amount of stress needed is determined by the individual’s vulnerability. Information can be gained on individual vulnerability differences by observing ICD patients because shock can be understood as a semiexperimentally defined stress likely to evoke panic attacks, which can then give rise to anxiety disorders. It would thus be possible to determine the influence of psychological, physiological, and biological traits.

There are some limitations to the present study. Multiple comparisons were made without correcting the error, and the validity and reliability of our ICD questionnaire are unknown. A Bonferroni adjustment for multiple testing in bivariate analysis of data would only have indicated a tendency toward higher shock frequency in anxiety disorders. Dysfunctional cognitions continue to differ significantly. Furthermore, the retrospective design does not disclose the time at which individuals increased their self-observation, developed a fear of renewed ICD shocks, and started living in a state of shock expectancy. A prospective study is needed to answer questions such as the following: Are fearful individuals more likely to develop anxiety disorders? Are catastrophe-linked thoughts already established before the onset of the anxiety disorder, or do they only arise during the course of the illness? Do patients who develop anxiety disorders observe their own bodies more intensively from the start?

Modern medicine can be intensive and can place patients under enormous psychological stress. Therefore, the psychological consequences of medical interventions must be seriously considered as potentially adverse reactions. It is important to develop additional psychological treatments to prevent these serious side effects.

Received for publication October 26, 1999.

	REFERENCES

TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES

 

1. Weissman MM, Bland RC, Canino GJ, Farvelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Welss JE, Wickramaratne PJ, Wittchen HU, Yeh EK. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997; 54: 305–9.[Abstract]
2. Joyce PR, Bushnell JA, Oakley-Browne MA, Wells JE, Hornblow AR. The epidemiology of panic symptomatology and agoraphobic avoidance. Compr Psychiatry 1989; 30: 303–12.[Medline]
3. Jefferson JW. Antidepressants in panic disorder. J Clin Psychiatry 1997; 58: 20–4.
4. Mellman TA, Uhde TW. Sleep panic attacks: new clinical findings and theoretical implications. Am J Psychiatry 1989; 146: 1204–7.[Abstract/Free Full Text]
5. Crowe RR, Noyes R, Pauls DL, Slymen D. A family study of panic disorder. Arch Gen Psychiatry 1983; 40: 1065–9.[Abstract]
6. Beck AT, Emery G, Greenberg RL. Anxiety disorders and phobias: a cognitive perspective. New York: Basic Books; 1985.
7. Clark DM. A cognitive model of panic attacks. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.
8. Carr RE, Lehrer PM, Hochron SM. Panic symptoms in asthma and panic disorder: a preliminary test of the dyspnea-fear theory. Behav Res Ther 1992; 30: 251–61.[Medline]
9. Ehlers A, Margraf J, Roth WT, Taylor CB, Maddock RJ, Sheikh J, Kopell ML, McClenahan KL, Gossard D, Blowers GH, Agras WS, Kopell BS. Lactate infusion and panic attacks: do patients and controls respond differently? Psychiatry Res 1986; 17: 295–308.[Medline]
10. Reinicker H. Phobien. Göttingen: Hogrefe; 1993.
11. Mowrer OH. A stimulus-response analysis of anxiety and its role as a reinforcement agent. Psychol Rev 1939; 46: 553–6.
12. Oest LG, Hugdahl K. Acquisition of agoraphobia, mode of onset and anxiety response patterns. Behav Res Ther 1983; 21: 623–31.[Medline]
13. Reinicker H, editor. Aversionstherapie. Salzburg: Müller; 1981.
14. Baker TB, Cannon DS, Tiffany ST, Gino A. Cardiac response as an index of the effect of aversion therapy. Behav Res Ther 1984; 22: 403–11.[Medline]
15. Ahmad T, Wardle J, Hayward P. Physical symptoms and illness attributions in agoraphobia and panic. Behav Res Ther 1992; 30: 493–500.[Medline]
16. Lazarus RS. Streß und Streßbewältigung - ein Paradigma. In: Filipp SH, editor. Kritische Lebensereignisse. München: Urban & Schwarzenberg; 1981.
17. Rapee RM, Brown TA, Antony MM, Borlow DH. Response to hyperventilation and inhalation of 5.5% carbon dioxide–enriched air across the DSM-III-R anxiety disorders. J Abnorm Psychol 1992; 101: 538–52.[Medline]
18. Hoehn-Saric R, McLeod DR, Zimmerli WD. Psychophysiological response patterns in panic disorder. Acta Psychiatr Scand 1991; 83: 4–11.[Medline]
19. Klein E, Cnaani E, Harel T, Braun S, Ben-Haim SA. Altered heart rate variability in panic disorder patients. Biol Psychiatry 1995; 37: 18–24.[Medline]
20. Yeragani VK, Pohl R, Berger R, Balon R, Ramesh C, Glitz D, Srinivasan K, Weinberg P. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1993; 46: 89–103.[Medline]
21. Eaton WW, Anthony JC, Romanoski A, Tien A, Gallo J, Cai G, Neufeld K, Schlaeper T, Laugharne J, Chen LS. Onset and recovery from panic disorder in the Baltimore Epidemiologic Catchment Area follow-up. Br J Psychiatry 1998; 173: 501–7.[Abstract/Free Full Text]
22. Yellowees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 1987; 146: 305–7.[Medline]
23. Yellowees PM, Haynes S, Potts S, Ruffin RE. Psychiatric morbidity in patients with life-threatening asthma. Med J Aust 1988; 149: 246–9.[Medline]
24. Karajgi B, Rifkin A, Doddi S, Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 1990; 147: 200–1.[Abstract/Free Full Text]
25. Shavitt RG, Gentil V, Mandetta R. The association of panic/agoraphobia and asthma: contributing factors and clinical implications. Gen Hosp Psychiatry 1992; 14: 420–3.[Medline]
26. Fleet RP, Dupuis G, Marchand A, Burelle D, Beitmann B. Panic disorder, chest pain and coronary artery disease: literature review. Can J Cardiol 1994; 10: 827–34.[Medline]
27. Eagger S, Luxon LM, Davies RA, Coelho A, Ron MA. Psychiatric morbidity in patients with peripheral vestibular disorder: a clinical and neuro-otological study. J Neurol Neurosurg Psychiatry 1992; 55: 383–7.[Abstract]
28. Eckhardt A, Tettenborn B, Krauthauser H, Thomalske C, Hartmann O, Hoffmann SO, Hopf HC. Vertigo and anxiety disorders: results of interdisciplinary evaluation. Laryngorhinootologie 1996; 75: 517–22.[Medline]
29. Herrmann C, von zur Mühen F, Schaumann A, Buss U, Kemper S, Wantzen C, Gonska B-D. Standardized assessment of psychological well-being and quality-of life in patients with implanted defibrillators. Pacing Clin Electrophysiol 1997; 20: 95–103.[Medline]
30. Keren R, Aarons D, Veltri EP. Anxiety and depression in patients with life-threatening ventricular arrhythmias: impact of the implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 1991; 14: 181–7.[Medline]
31. Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias: responses after automatic internal cardioverter defibrillator implantation. Pacing Clin Electrophysiol 1989; 12: 366–73.[Medline]
32. Fricchione GL, Olson LC, Vlay SC. Psychiatric syndromes in patients with the automatic internal cardioverter defibrillator: anxiety, psychological dependence, abuse and withdrawal. Am Heart J 1989; 117: 1411–5.[Medline]
33. Horowitz LN. The automatic implantable cardioverter defibrillator: review of clinical results, 1980–1990. Pacing Clin Electrophysiol 1992; 15: 604–9.[Medline]
34. Kuck K-H, Siebels J, Schlüter M, Meinertz T. [The implantable cardioverter/defibrillator]. Herz 1994;19:287–93. German.
35. Moss AJ, Jackson HW, Cannom CS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmia. N Engl J Med 1996; 335: 1933–40.[Abstract/Free Full Text]
36. Nisam S, Mower MM, Thomas A, Hauser R. Patient survival comparison of three generations of automatic implantable cardioverter/defibrillator: review of 12 years, 25,000 patients. Pacing Clin Electrophysiol 1993; 16: 174–8.[Medline]
37. Chevalier P, Verrier P, Kirkorian G, Touboul P, Cottraux J. Improved appraisal of quality of life in patients with automatic implantable cardioverter defibrillator. Psychother Psychosom 1996; 65: 49–56.[Medline]
38. Morris PL, Badger RN, Chmielewski C, Berger E, Goldberg RJ. Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics 1991; 32: 58–64.[Abstract/Free Full Text]
39. Bourke JP, Turkington D, Thomas G, McComb JM, Tynan M. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators. Heart 1997; 78: 581–3.[Abstract/Free Full Text]
40. Fricchione GL, Olson LC, Vlay SC. Cardiac psychiatry and the management of malignant ventricular arrhythmias with the internal cardioverter-defibrillator. Am Heart J 1994; 128: 1050–9.[Medline]
41. Crow SJ, Colling J, Justic M, Goetc R, Adler S. Psychopathology following cardioverter defibrillator implantation. Psychosomatics 1998; 39: 305–10.[Abstract/Free Full Text]
42. Pauli P, Wiedemann G, Dengler W, Blaumann-Benninghoff G, Kuehlkamp V. Anxiety in patients with an automatic implantable cardioverter defibrillator: what differentiates them from panic patients? Psychosom Med 1999; 61: 69–76.[Abstract/Free Full Text]
43. Lüderitz B, Jung W, Deister A, Marneros A, Manz M. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 1993; 16: 1815–21.[Medline]
44. Margraf J, editor. Diagnostic Interview of Psychiatric Disease (DIPS). Berlin: 1994.
45. Derogatis LR. SCL-90-R: self-report symptom inventory. In: Collegium Internationale Psychiatriae Scalarum. Weinheim: Belz; 1986.
46. Chambless DL, Caput GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 1984; 52: 1090–7.[Medline]
47. DSM-III-R. Diagnostic and statistical manual of mental disorders. 3rd ed revised. Washington DC: American Psychiatric Association; 1987.
48. Behrens S, Galecka M, Ehlers C, Brüggemann T, Willich S, Dissmann R, Ziss W, Andresen D. Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator. Am Heart J 1995; 130: 79–84.[Medline]
49. Goldberg R, Morris P, Christian F, Badger J, Chabot S, Edlung M. Panic disorder in cardiac outpatients. Psychosomatics 1990; 31: 168–73.[Abstract/Free Full Text]
50. Schöhl W, Trappe H, Liehtlein PR. Acceptance and quality of life after implantation of an automatic cardioverter/defibrillator. Z Kardiol 1994; 83: 927–32.[Medline]
51. Dunbar SB, Jenkins LS, Hawthorne M, Kimble LP, Duley WN, Slemmons M, Purcell JA. Factors associated with outcomes 3 months after implantable cardioverter defibrillator insertion. Heart Lung 1999; 28: 303–15.[Medline]
52. Hamner M, Hunt N, Gee J, Barrell R, Monroe R. PTSD and automatic implantable cardioverter defibrillators. Psychosomatics 1999; 40: 82–5.[Free Full Text]
53. Hegel TH, Griegel LE, Black C, Goulden L. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. Int J Psychiatry Med 1997; 27: 57–69.[Medline]
54. Reiss S. Trait anxiety: it’s not what you think it is. J Anxiety Disord 1997; 11: 201–14.[Medline]
55. Margraf J, Schneider S, editors. Panic. Panic attacks and their treatment. 2nd ed revised. Berlin: 1990.

This article has been cited by other articles:

				R. Tung, P. Zimetbaum, and M. E. Josephson A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1111 - 1121. [Abstract] [Full Text] [PDF]

				M. Esler, M. Alvarenga, C. Pier, J. Richards, A. El-Osta, D. Barton, D. Haikerwal, D. Kaye, M. Schlaich, L. Guo, et al. The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol, July 1, 2006; 20(4 Suppl): 60 - 66. [Abstract] [PDF]

				M. E. Alvarenga, J. C. Richards, G. Lambert, and M. D. Esler Psychophysiological Mechanisms in Panic Disorder: A Correlative Analysis of Noradrenaline Spillover, Neuronal Noradrenaline Reuptake, Power Spectral Analysis of Heart Rate Variability, and Psychological Variables Psychosom Med, January 1, 2006; 68(1): 8 - 16. [Abstract] [Full Text] [PDF]

				J. K. Schulman, P. R. Muskin, and P. A. Shapiro Psychiatry and Cardiovascular Disease Focus, April 1, 2005; 3(2): 208 - 224. [Abstract] [Full Text] [PDF]

				K.-H. Ladwig, B. Marten-Mittag, I. Deisenhofer, B. Hofmann, J. Schapperer, S. Weyerbrock, and C. Schmitt Exaggerated Electrodermal Startle Responses After Intracardiac Shock Discharges in Patients With Implanted Cardioverter Defibrillators Psychosom Med, March 1, 2003; 65(2): 222 - 228. [Abstract] [Full Text] [PDF]

				J. E. Dimsdale Comorbidity Studies: A Core Area for Psychosomatic Research Psychosom Med, March 1, 2001; 63(2): 201 - 202. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Godemann, F. Articles by Linden, M. Search for Related Content PubMed PubMed Citation Articles by Godemann, F. Articles by Linden, M. Related Collections Anxiety Other Cardiovascular Medicine